Your donation will make a difference:
Cystic Fibrosis Trust

Please Log in

Log in

Not a registered user? Register with us

This trial has been added to your watchlist.

Do you want to receive email notifications when the trial status changes?

No Yes

Unfollowing a trial will remove it from the watchlist and stop status change email notifications

Are you sure you want to unfollow this trial?

Yes, remove from watchlist

Virtual Care in CF (VIRTUAL-CF)


Therapeutic category
the type of treatment or therapy being studied. A therapy could range from a medication addressing a particular characteristic of CF to a device or activity e.g. exercise


Trial status


Participating Centres
the different stages involved in the development of a new medication. Phase I focuses on initial safety in people. Phase 2 evaluates safety, correct dose and early signs of whether the medication works. Phase 3 is the stage before medication licensing and looks at safety and medication effectiveness. Phase 4 evaluates longer term use of a medication after it has been licensed for use


Full title

Virtual Care in CF (VIRTUAL-CF)

This study aims to find out if CF patients benefit from ‘virtual care’ while they are receiving intravenous (IV) antibiotics in the community. ‘Virtual care’ is a term that we are using to describe the provision of regular videoconferencing with the CF team as well as equipment to allow patients to monitor their own lung function and oxygen saturations.

Trial Reference Number


Trial type


Length of participation
the length of time a participant will take part in a trial, from the first to the last appointment

2 weeks

the name of the treatment or therapy being researched

Virtual Care, Routine Care

Recruitment target
the number of participants who need to be recruited for the trial in the UK


Last edited date

22 December 2017

CF sponsor

Heart of England NHS Trust

CF sponsor type


Who can take part?



Top inclusion criteria
  • CF diagnosis confirmed by clinical characteristics, sweat test +/- genetic testing.
  • Patient has been assessed by the clinical team to require a course of community-delivered intravenous antibiotics
Top exclusion criteria
  • Patients who are currently participating in another clinical trial (excluding observational studies).
  • Pneumothorax or lung surgery within the previous 3 months, eye surgery (e.g. cataract operation) in the previous 4 weeks, or any other factor that prevents measurement of spirometry

CF centres running this trial


Heart of England NHS Foundation Trust


Birmingham Heartlands Hospital Bordesley Green East Birmingham West Midlands B9 5SS

Recruitment starts

December 2016

Recruitment ends

December 2017


Nash, Edward

Get in touch